In two studies with over 3,000 women and children who had a mild UTI, Blujepa, a pill taken twice a day for five days, worked as well as or better than nitrofurantoin, a common UTI antibiotic.

Urinary tract infections (UTIs) are among the most common medical issues women experience; up to 60% of women will get one during their lifetime. Older, post-menopausal women are especially ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and adolescent girls. The drug is made by British pharmaceutical company GSK.

[Reuters] The FDA approved a new antibiotic to treat UTIs, which affect about half of all women at least once in their lives. Drugmaker GSK hailed the twice-daily pill as a new treatment option ...

Urinary tract infections (UTIs) are among the most common medical issues women experience; up to 60% of women will get one during their lifetime. Older, post-menopausal women are especially ...

A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time in decades. It’s an oral pill called Blujepa from the London-based ...

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...